Effect of Lactobacillus salivarius Ls-33 on fecal microbiota in obese adolescents

Clinical Nutrition

Volumn 32, Issue 6, 2013, Pages 935-940

  Larsen, Nadja ^a   Vogensen, Finn K ^a   Gøbel, Rikke Juul ^a   Michaelsen, Kim F ^a   Forssten, Sofia D ^b   Lahtinen, Sampo J ^b   Jakobsen, Mogens ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Health and Nutrition   (Finland)

Author keywords

Fecal microbiota; Lactobacillus salivarius; Obesity; Probiotics

Indexed keywords

PLACEBO; PROBIOTIC AGENT; SHORT CHAIN FATTY ACID;

ADOLESCENT; ARTICLE; BACTERIAL COUNT; BACTERIAL STRAIN; BACTEROIDES; BIFIDOBACTERIUM; BLAUTIA COCCOIDES; CHILD; CLINICAL ARTICLE; CLOSTRIDIUM; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENTEROBACTERIACEAE; ENTEROCOCCUS; EUBACTERIA RECTALE GROUP; EUBACTERIUM; FAECALIBACTERIUM PRAUSNITZII; FECES MICROFLORA; FIRMICUTES; GAS CHROMATOGRAPHY; HUMAN; LACTOBACILLUS; LACTOBACILLUS SALIVARIUS; LACTOBACILLUS SALIVARIUS LS 33; METABOLIC SYNDROME X; NONHUMAN; OBESITY; PORPHYROMONAS; PREVOTELLA; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION; ROSEBURIA INTESTINALIS; SCHOOL CHILD;

FECAL MICROBIOTA; LACTOBACILLUS SALIVARIUS; OBESITY; PROBIOTICS;

ADOLESCENT; CHILD; DNA, BACTERIAL; DOUBLE-BLIND METHOD; FATTY ACIDS, VOLATILE; FECES; GRAM-POSITIVE BACTERIA; HUMANS; LACTOBACILLUS; METABOLIC SYNDROME X; MICROBIOTA; OBESITY; PROBIOTICS;

EID: 84887621737     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2013.02.007     Document Type: Article

References (27)

1. Raftis E.J., Salvetti E., Torriani S., Felis G.E., O'Toole P.W. Genomic diversity of Lactobacillus salivarius. Appl Environ Microbiol 2011, 77:954-965.
2. Collins J.K., Dunne C., Murphy L., Morrissey D., O"Mahony L., O"Sullivan E., et al. Arandomised controlled trial of a probiotic Lactobacillus strain in healthy adults: assessment of its delivery, transit and influence on microbial flora and enteric immunity. Microb Ecol Health Dis 2002, 14:81-89.
3. Maldonado J., Lara-Villoslada F., Sierra S., Sempere L., Gomez M., Rodriguez J.M., et al. Safety and tolerance of the human milk probiotic strain Lactobacillus salivarius CECT5713 in 6-month-old children. Nutrition 2010, 26:1082-1087.
4. Sierra S., Lara-Villoslada F., Sempere L., Olivares M., Boza J., Xaus J. Intestinal and immunological effects of daily oral administration of Lactobacillus salivarius CECT5713 to healthy adults. Anaerobe 2010, 16:195-200.
5. Svetoch E.A., Eruslanov B.V., Levchuk V.P., Perelygin V.V., Mitsevich E.V., Mitsevich I.P., et al. Isolation of Lactobacillus salivarius 1077 (NRRL B-50053) and characterization of its bacteriocin, including the antimicrobial activity spectrum. Appl Environ Microbiol 2011, 77:2749-2754.
6. Perez-Cano F.J., Dong H., Yaqoob P. Invitro immunomodulatory activity of Lactobacillus fermentum CECT5716 and Lactobacillus salivarius CECT5713: two probiotic strains isolated from human breast milk. Immunobiology 2010, 215:996-1004.
7. Zhang J., Deng J., Wang Z., Che C., Li Y.F., Yang Q. Modulatory effects of Lactobacillus salivarius on intestinal mucosal immunity of piglets. Curr Microbiol 2011, 62:1623-1631.
8. Larsen N., Vogensen F.K., van den Berg F.W., Nielsen D.S., Andreasen A.S., Pedersen B.K., et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 2010, 5:e9085.
9. Ley R.E., Turnbaugh P.J., Klein S., Gordon J.I. Microbial ecology: human gut microbes associated with obesity. Nature 2006, 444:1022-1023.
10. Nadal I., Santacruz A., Marcos A., Warnberg J., Garagorri M., Moreno L.A., et al. Shifts in clostridia, bacteroides and immunoglobulin-coating fecal bacteria associated with weight loss in obese adolescents. Int J Obes 2009, 33:758-767.
11. Santacruz A., Marcos A., Warnberg J., Marti A., Martin-Matillas M., Campoy C., et al. Interplay between weight loss and gut microbiota composition in overweight adolescents. Obesity 2009, 17:1906-1915.
12. Daniel C., Poiret S., Goudercourt D., Dennin V., Leyer G., Pot B. Selecting lactic acid bacteria for their safety and functionality by use of a mouse colitis model. Appl Environ Microbiol 2006, 72:5799-5805.
13. Gøbel R.J., Larsen N., Jakobsen M., Molgaard C., Michaelsen K.F. Probiotics to obese adolescents; RCT examining the effects on inflammation and metabolic syndrome. JPediatr Gastroenterol Nutr 2012, 55:673-678.
14. Gøbel R.J., Jensen S.M., Frøkiær H., Molgaard C., Michaelsen K.F. Obesity, inflammation and metabolic syndrome in Danish adolescents. Acta Paediatr 2012, 101:192-200.
15. Harrow S.A., Ravindran V., Butler R.C., Marshall J.W., Tannock G.W. Real-time quantitative PCR measurement of ileal Lactobacillus salivarius populations from broiler chickens to determine the influence of farming practices. Appl Environ Microbiol 2007, 73:7123-7127.
16. Heilig H.G.H.J., Zoetendal E.G., Vaughan E.E., Marteau P., Akkermans A.D.L., de Vos W.M. Molecular diversity of Lactobacillus spp. and other lactic acid bacteria in the human intestine as determined by specific amplification of 16S ribosomal DNA. Appl Environ Microbiol 2002, 68:114-123.
17. Makivuokko H., Nurmi J., Nurminen P., Stowell J., Rautonen N. Invitro effects on polydextrose by colonic bacteria and caco-2 cell cyclooxygenase gene expression. Nutr Cancer 2005, 52:94-104.
18. Makivuokko H., Forssten S., Saarinen M., Ouwehand A.C., Rautonen N. Synbiotic effects of lactitol and Lactobacillus acidophilus NCFM™ in a semi-continuous colon fermentation model. JBeneficial Microbes 2010, 1:131-137.
19. Matsuda K., Tsuji H., Asahara T., Kado Y., Nomoto K. Sensitive quantitative detection of commensal bacteria by rRNA-targeted reverse transcription-PCR. Appl Environ Microbiol 2007, 73(1):32-39.
20. Matsuki T., Watanabe K., Fujimoto J., Takada T., Tanaka R. Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human feces. Appl Environ Microbiol 2004, 70:7220-7228.
21. Rinttila T., Kassinen A., Malinen E., Krogius L., Palva A. Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. JAppl Microbiol 2004, 97:1166-1177.
22. Song Y., Liu C., Finegold S.M. Real-time PCR quantitation of clostridia in feces of autistic children. Appl Environ Microbiol 2004, 70:6459-6465.
23. Holben W.E., Williams P., Gilbert M.A., Saarinen M., Sarkilahti L.K., Apajalahti J.H. Phylogenetic analysis of intestinal microflora indicates a novel Mycoplasma phylotype in farmed and wild salmon. Microb Ecol 2002, 44:175-185.
24. Tiihonen K., Ouwehand A.C., Rautonen N. Effect of overweight on gastrointestinal microbiology and immunology: correlation with blood biomarkers. Br J Nutr 2010, 103:1070-1078.
25. Klose V., Bayer K., Bruckbeck R., Schatzmayr G., Loibner A.P. Invitro antagonistic activities of animal intestinal strains against swine-associated pathogens. Vet Microbiol 2010, 144:515-521.
26. Valerio F., de C.S., Lonigro S.L., Russo F., Riezzo G., Orlando A., et al. Role of the probiotic strain Lactobacillus paracasei LMGP22043 carried by artichokes in influencing faecal bacteria and biochemical parameters in human subjects. JAppl Microbiol 2011, 111:155-164.
27. Schwiertz A., Taras D., Schafer K., Beijer S., Bos N.A., Donus C., et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring) 2010, 18:190-195.